Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kayla Johnson

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The Mental Health Clinician|December 20, 2024
Clinical experience and treatment considerations with vesicular monoamine transport 2 inhibitorsKayla Johnson
Accident; Analysis and Prevention|May 2, 2015
Real-time driver drowsiness feedback improves driver alertness and self-reported driving performanceEugene Aidman, Carolyn Chadunow, Kayla Johnson, et al.
Southern Medical Journal|February 4, 2017
Breaking Bad Delirium: Methamphetamine and Boric Acid Toxicity with Hallucinations and PseudosepsisKayla Johnson, Joanna L Stollings, E Wesley Ely
Behavioural Brain Research|July 18, 2021
Loss of SUR1 subtype K<sub>ATP</sub> channels alters antinociception and locomotor activity after opioid administrationGerald Sakamaki, Kayla Johnson, Megan Mensinger, et al.
Arxiv|August 26, 2024
Computational strategies for cross-species knowledge transfer and translational biomedicineHao Yuan, Christopher A Mancuso, Kayla Johnson, et al.
Nature Methods|December 13, 2025
Computational strategies for cross-species knowledge transferHao Yuan, Christopher A Mancuso, Kayla Johnson, et al.
Body Image|December 9, 2025
Changes in weight talk and links with body satisfaction across adolescence and young adulthoodAnna K Hochgraf, Kayla Johnson, Annie Youngblood, et al.
Journal of Huntington'S Disease|March 24, 2025
Deutetrabenazine treatment outcomes with doses above U.S. Food and Drug Administration maximum approved doses in Huntington's disease chorea: A dual-site analysisKayla Dodson, Sabrina Livezey, Brittany Denson, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 20, 2026
Clinical and economic benefits of pharmacist interventions in a non-multiple sclerosis neurology clinicKayla Johnson, Morteza Kaveh, Sabrina Livezey, et al.
Journal of the American Pharmacists Association : Japha|August 19, 2022
Specialty pharmacy integration and the role of an advanced certified pharmacy technician in prescription cannabidiol accessWendi Owens, Holly Dial, Josh DeClercq, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The Mental Health Clinician|December 20, 2024
Clinical experience and treatment considerations with vesicular monoamine transport 2 inhibitorsKayla Johnson
Accident; Analysis and Prevention|May 2, 2015
Real-time driver drowsiness feedback improves driver alertness and self-reported driving performanceEugene Aidman, Carolyn Chadunow, Kayla Johnson, et al.
Southern Medical Journal|February 4, 2017
Breaking Bad Delirium: Methamphetamine and Boric Acid Toxicity with Hallucinations and PseudosepsisKayla Johnson, Joanna L Stollings, E Wesley Ely
Behavioural Brain Research|July 18, 2021
Loss of SUR1 subtype K<sub>ATP</sub> channels alters antinociception and locomotor activity after opioid administrationGerald Sakamaki, Kayla Johnson, Megan Mensinger, et al.
Arxiv|August 26, 2024
Computational strategies for cross-species knowledge transfer and translational biomedicineHao Yuan, Christopher A Mancuso, Kayla Johnson, et al.
Nature Methods|December 13, 2025
Computational strategies for cross-species knowledge transferHao Yuan, Christopher A Mancuso, Kayla Johnson, et al.
Body Image|December 9, 2025
Changes in weight talk and links with body satisfaction across adolescence and young adulthoodAnna K Hochgraf, Kayla Johnson, Annie Youngblood, et al.
Journal of Huntington'S Disease|March 24, 2025
Deutetrabenazine treatment outcomes with doses above U.S. Food and Drug Administration maximum approved doses in Huntington's disease chorea: A dual-site analysisKayla Dodson, Sabrina Livezey, Brittany Denson, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 20, 2026
Clinical and economic benefits of pharmacist interventions in a non-multiple sclerosis neurology clinicKayla Johnson, Morteza Kaveh, Sabrina Livezey, et al.
Journal of the American Pharmacists Association : Japha|August 19, 2022
Specialty pharmacy integration and the role of an advanced certified pharmacy technician in prescription cannabidiol accessWendi Owens, Holly Dial, Josh DeClercq, et al.
Pageof 3